Katzenellenbogen, Benita S.
Guillen, Valeria Sanabria
Katzenellenbogen, John A.
Funding for this research was provided by:
Breast Cancer Research Foundation (BCRF-083, BCRF-084)
National Institutes of Health (1R01 CA220284, T32 GMO70421, 1R01 CA220284)
Article History
Received: 20 March 2023
Accepted: 17 June 2023
First Online: 27 June 2023
Declarations
:
: Not applicable.
: B.S.K. and J.A.K. are co-inventors on a Provisional Application filed by the University of Illinois to cover some of the FOXM1 inhibitor compounds described herein. The other author (V.S.G.) declares no competing interests.